SAM #75N98026R00146

Longitudinal Research Support for Sickle Cell Disease Transformative Therapies (WARRIOR-SCD)

The National Institutes of Health (NIH), through the National Heart, Lung, and Blood Institute (NHLBI) and the Office of Acquisition and Logistics Management (OALM), is seeking contractor support for the WARRIOR-SCD study, a major longitudinal research initiative: - Government Buyer: - Department of Health and Human Services (HHS) - National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute (NHLBI) - Office of Acquisition and Logistics Management (OALM), Research and Development and Professional Services Division B - Project Scope: - Contractor support for the Whole-person Assessment of Response and Risk after transformative therapies: Investigating Outcomes and Resilience in Sickle Cell Disease (WARRIOR-SCD) - 15-year longitudinal study focused on long-term outcomes of gene therapy (GT) and hematopoietic cell transplantation (HCT) in sickle cell disease patients - Approximately 700 participants to be enrolled - Collection of clinical data, patient-reported outcomes, and biospecimens - Services Requested: - Study design and implementation - Data management and statistical analysis - Participant engagement and biospecimen coordination - Support for ancillary studies and dissemination of findings - Unique Requirements: - Multi-center program management for a large, diverse patient population - Long-term follow-up and data collection over a decade - Integration of clinical, patient-reported, and biological data - No specific OEMs, products, or part numbers are mentioned; the opportunity is focused on research and program management services.

Description

Whole-person Assessment of Response and Risk after transformative therapies: Investigating Outcomes and Resilience in Sickle Cell Disease (WARRIOR-SCD)

View original listing